OVID

Ovid Therapeutics (OVID)

About Ovid Therapeutics (OVID)

Ovid Therapeutics, Inc. is a biopharmaceutical company dedicated to pioneering better, gentler medicines for the brain. It discovers and develops differentiated, small molecule medicines for neurological and neuropsychiatric disorders with significant unmet need. The company was founded by Matthew During and Jeremy M. Levin on April 1, 2014 and is headquartered in New York, NY.

Details

Daily high

$2.33

Daily low

$2.19

Price at open

$2.20

52 Week High

$3.10

52 Week Low

$0.29

Market cap

419.9M

Dividend yield

0.00%

Volume

2.4M

Avg. volume

2.6M

P/E ratio

-9.25

Ovid Therapeutics News